6th Jun 2019 15:54
LONDON (Alliance News) - Oxford BioDynamics PLC said Thursday that Vulpes Life Sciences Fund, controlled by Non-Executive Director Steven Diggle, purchased around GBP12,700 in shares in a transaction on Wednesday.
The fund bought 9,300 shares at a price of GBP1.37 per share. Following this deal, Vulpes Life Sciences now holds 11.6 million shares overall, reflecting a 13% interest in the company.
Shares in the biotechnology firm were down 1.4% at 140.00 pence on Thursday.
Related Shares:
Oxford Biodyn